The evaluation of immunological safety of the CombiHIVvac candidate vaccine against HIV-1

被引：0
|
作者：
Gamaley, S. G. [1 ]
Sysoeva, G. M. [1 ]
Danilenko, E. D. [1 ]
Masycheva, V. I. [1 ]
Karpenko, L. I. [1 ]
机构：
[1] FSRI State Res Ctr Virol & Biotechnol Vector, Koltsov, Novosibirsk Reg, Russia
来源：
CYTOKINE | 2009年 / 48卷 / 1-2期
关键词：
D O I：
10.1016/j.cyto.2009.07.242
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：73 / 73
页数：1
相关论文
共 50 条
  • [1] Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine
    Graham, Barney S.
    Koup, Richard A.
    Roederer, Mario
    Bailer, Robert T.
    Enama, Mary E.
    Moodie, Zoe
    Martin, Julie E.
    McCluskey, Margaret M.
    Chakrabarti, Bimal K.
    Lamoreaux, Laurie
    Andrews, Charla A.
    Gomez, Phillip L.
    Mascola, John R.
    Nabel, Gary J.
    JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (12): : 1650 - 1660
  • [2] HIV-1 vaccine candidate evaluation in non-human primates
    Lu, YC
    CRITICAL REVIEWS IN ONCOGENESIS, 1997, 8 (2-3): : 273 - 291
  • [3] Preformulation study of the vaccine candidate TAB9 against HIV-1
    Raya, NE
    Díaz, AG
    López, YC
    Vazquez, DQ
    Díaz, DP
    de la Puente, NM
    Cano, CD
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2002, 36 : 149 - 153
  • [4] Development of a multicomponent candidate vaccine for HIV-1
    Kim, JJ
    Ayyavoo, V
    Bagarazzi, ML
    Chattergoon, M
    Boyer, JD
    Wang, B
    Weiner, BD
    VACCINE, 1997, 15 (08) : 879 - 883
  • [5] CombiHIVvac vaccine which contains polyepitope band T-cell immunogens of HIV-1
    Karpenko, L. I.
    Bazhan, S. I.
    Eroshkin, A. M.
    Lebedev, L. R.
    Uzhachenko, R. V.
    Nekrasova, N. A.
    Plyasunova, O. A.
    Belavin, P. A.
    Seregin, S. V.
    Danilyuk, N. K.
    Danilenko, E. D.
    Zaitsev, B. N.
    Masicheva, V. I.
    Ilyichev, A. A.
    Sandakhchiev, L. S.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2007, 413 (01) : 65 - 67
  • [6] Synthesis and Immunological Evaluation of Pentamannose-Based HIV-1 Vaccine Candidates
    Liu, Chang-Cheng
    Huo, Chang-Xin
    Zhai, Canjia
    Zheng, Xiu-Jing
    Xiong, De-Cai
    Ye, Xin-Shan
    BIOCONJUGATE CHEMISTRY, 2022, 33 (05) : 807 - 820
  • [7] Polynucleotide vaccine against HIV-1
    Moelling, K
    RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 1996, : 303 - 307
  • [8] Multicenter study of safety and immunogenicity of HIV-1 rgp160 candidate vaccine in seropositive HIV-1 volunteers.
    Goebel, FD
    Mannhalter, JW
    Eibl, MM
    Belshe, RB
    Grob, P
    Erfle, V
    Griffiths, PD
    Wahren, B
    Krohn, K
    Kunschak, M
    Engl, W
    AIDS, 1996, 10 : OP64 - OP64
  • [9] Evaluation of safety and efficacy of RNAi against HIV-1 in vivo
    Von Eije, Karin J.
    ter Brake, Olivier
    Centlivre, Mireille
    Weijer, Kees
    Blom, Bianca
    Legrand, Nicolas
    Berkhout, Ben
    HUMAN GENE THERAPY, 2007, 18 (10) : 1087 - 1087
  • [10] RNA LESS HIV-1 PSEUDOVIRIONS AS A CANDIDATE VACCINE
    HALBREICH, A
    BIZZINI, B
    ACHOUR, A
    POLLIOTTI, B
    BERTHO, JM
    LACHGAR, A
    LANNEVAL, K
    NIRHANE, A
    BERNARD, J
    PICARD, O
    CARELLI, C
    ZAGURY, D
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (05) : 944 - 944
12345